Therapeutic effect of gevilon in patients with hyperlipoproteinaemia.
Authors examined 46 patients with hyperlipoproteinaemia divided according to hyperlipoproteinaemia type II A, II B, IV. After one month of isocaloric diet the patients were given a single night gevilon dose of 900 mg for a period of 3 months. After therapy we examined lipid metabolism, liver and kidney function, carbohydrate metabolism, hematopoietic system and water--electrolyte balance. In all groups increased levels of cholesterol, beta-lipoproteins and triglycerides were significantly reduced after 3 months of gevilon treatment. In all patients the HDL/LDL ratio increased close to normal values. No impairment of kidney or liver function hematopoietic system and electrolyte balance after 3 months of treatment were noted. Because gevilon is easy to apply and has a limited number of side effects, it is very readily taken by the patients who have lipid balance disorders.
Milewicz
A
A
Department of Endocrinology, Medical Academy, Wrocław, Poland.
Plamieniak
Z
Z
Bohdanowicz-Pawlak
A
A
D000085:Acetates / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D003509:Cyclohexanecarboxylic Acids; D005260:Female; D006801:Humans; D006951:Hyperlipoproteinemias / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D000085:Acetates; D003509:Cyclohexanecarboxylic Acids; C082676:gevilon